Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis

Leukemia Research

Volumn 21, Issue 1, 1997, Pages 37-43

  Verdonck, Leo F ^a   Van Heugten, Hans G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acute leukemia; Apoptosis; Ether lipid; Multidrug resistance

Indexed keywords

ANTILEUKEMIC AGENT; CYTOTOXIC AGENT; ETHER LIPID; THYMIDINE; TRITIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; APOPTOSIS; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CLINICAL ARTICLE; DNA SYNTHESIS INHIBITION; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; TUMOR STEM CELL ASSAY;

EID: 0031018831     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00047-1     Document Type: Article

References (36)

1. 1. Dalton W. S. (1993) Drug resistance modulation in the laboratory and the clinic. Sem. Oncol. 20, 64.
2. 2. Kartner N., Riordan J. R, & Ling V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, 1285.
3. 3. Cornwell M. M., Safa A. R., Felsted R. L., Gottesman M. M. & Pastan I. (1986) Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc. natl. Acad. Sci. USA 83, 3847.
4. 4. Chen C., Chin J. E., Ueda K., Clark D. R., Pastan I., Gottesman M. M. & Roninson I. B. (1986) Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381.
5. 5. Croop J. M., Gros P. & Housman D. E. (1988) Genetics of multidrug resistance. J. Clin. Invest. 81, 1303.
6. 6. Sato H., Preisler H., Day R., Raza A., Larson R., Browman G., Goldberg J., Vogler R., Grunwald H., Gottlieb A., Bennet J., Gottesman M. & Pastan I. (1990) MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br. J. Haematol. 75, 340.
7. 7. Marie J.-P., Zittoun R. & Sikic B. I. (1991) Multidrug resistance (MDR1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78, 586.
8. 8. Pirker R., Wallner J., Geissler K., Linkesh W., Haas O. A., Bettelheim P., Hopfner M., Scherrer R., Valent P., Havelec L., Ludwig H. & Lechner K. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. 83, 708.
9. 9. Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D. & Fiere D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79, 473.
10. 10. Goasguen J. E., Dossot J.-M., Fardel O., Le Mee F., Le Gall E., Leblay R., LePrise P. Y., Chaperon J. & Fauchet R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 81, 2394.
11. 11. Nooter K., Sonneveld P., Oostrum R., Herweijer H., Hagenbeek T. & Valerio D. (1990) Overexpression of the MDR1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. Int. J. Cancer 45, 263.
12. 12. Salmon S. E., Dalton W. S., Grogan T. M., Plezia P., Lehnert M,, Roe D. J. & Miller T. P. (1991) Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78, 44.
13. 13. Berman E. & McBride M. (1992) Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells. Blood 79, 3267.
14. 14. Sonneveld P. & Nooter K. (1990) Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br. J. Haematol. 75, 208.
15. 15. Ross D. D., Wooten P. J., Sridhara R., Ordóñez J. V., Lee E. J. & Schiffer C. A. (1993) Enhancement of daunorubicin in accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia. Blood 82, 1288.
16. 16. Ross D. D., Wooten P. J., Tong Y., Cornblatt B., Levy C., Sridhara R., Lee E. J. & Schiffer C. A. (1994) Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL. Blood 83, 1337.
17. 17. Andreesen R., Modolell M., Weltzien H. U., Eibl H., Common H. H., Lohr G. W. & Munder P. G. (1978) Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Res. 38, 3894.
18. 18. Hoffman D. R., Hoffman L. H. & Snyder F. (1986) Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Cancer Res. 46, 5803.
19. 19. Verdonck L. F., Witteveen E. O., Heugten H. G. van, Rozemuller E. & Rijksen G. (1990) Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid. Cancer Res. 50, 4020.
20. 20. Verdonck L. F., Heesbeen E. C., Heugten H. G. van, Staal G. E. J. & Rijksen G. (1992) The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation. Bone Marrow Transplant. 9, 241.
21. 21. Okamoto S., Olson A. C., Vogler W. R. & Winton E. F. (1987) Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid. Blood 69, 1381.
22. 22. Okamoto S., Olson A. C., Berdel W. E. & Vogler W. R. (1988) Purging of acute myeloid leukemic cells by ether lipids and hyperthermia. Blood 72, 1777.
23. 23. Vogler W. R., Berdel W. E., Olson A. C., Winton E. F., Heffner L. T. & Gordon D. S. (1992) Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood 80, 1423.
24. 24. Unger C., Eibl H., Von Heyden H. W., Peukert M., Sindermann H. & Nigel G. A. (1990) Phase I study with daily hexadecylphosphocholine in patients with malignant disease. J. Cancer Res. Clin. Oncol. 116(abstract), 993.
25. 25. Berdel W. E., Bechner R., Edler L., Bremer K., Essers U., Drozd A., Zafferani M., Klee M. A. G., Bachmann P., Korfel A. & Westerhausen M. (1992) Daily oral miltefosine (hexadecyl-phosphocholine) in patients with advanced non-small cell lung cancer. A Phase II study. Onkologie 15, 238.
26. 26. Diomede L., Bizzi A., Magistrelli A., Modest E. J., Salmona M. & Noseda A. (1990) Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity. Int. J. Cancer 46, 341.
27. 3 acts as an activator of protein kinase C in HL-60 cells. FEBS Letters 290, 231.
28. 28. Wagner B. A., Buettner G. R. & Burns C. P. (1992) Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents. Cancer Res. 52, 6045.
29. 29. Petersen E. S., Kelley E. E., Modest E. J. & Burns C. P. (1992) Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440. Cancer Res. 52, 6263.
30. 3 by HL-60 cells during induction of differentiation by dimethylsulfoxide. Leukemia Res. 17, 143.
31. 31. Heesbeen E. C., Verdonck L, F., Staal G. E. J. & Rijksen G. (1994) Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Biochem. Pharmacol. 47, 1481.
32. 32. Koopman G., Reutelingsperger C. P. M., Kuijten G. A. M., Keehnen R. M. J., Pals S. T. & Oers M. H. J. van (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415.
33. 33. Vehmeyer K., Eibl H. & Unger C. (1992) Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoietic progenitor cells. Exp. Hematol. 20, 1.
34. 34. Drings P., Günther I., Gatzemeier U., Ulbrich F., Khanavkar B., Schreml W., Lorenz J., Brugger W., Schick H. D., Pawel J. v. & Nordström R. (1992) Final evaluation of a phase II study on the effect of edelfosine (an ether lipid) in advanced non-small-cell bronchogenic carcinoma. Onkologie 15, 375.
35. 35. Diomede L., Colotta F., Piovani B., Re F., Modest E. J. & Salmona M. (1993) Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-RAC-glycero-3-phosphocholine. A possible basis for its selective action. Int. J. Cancer 53, 124.
36. 36. Diomede L., Piovani B., Re F., Principe P., Colotta F., Modest E. J. & Salmona M. (1994) The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int. J. Cancer 57, 645.